PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells.
Authors: E Glodkowska-Mrowka, A Manda-Handzlik, A Stelmaszczyk-Emmel, I Seferynska,3 T Stoklosa,J Przybylski, P Mrowka
Published in: Blood Cancer Journal
Publication type: article
Subject areas: Medicine
SJR best quartile: Q1